What it takes to make AI work in biopharma: CSL & Visium at BiotechX 2026

AI in biopharma is easy to prototype and hard to put into production, especially in a regulated company.

In this BiotechX 2026 keynote, Iftikar Sunny (Head of AI Platforms & Engineering, CSL) and Kelly Petrou (Senior AI Manager, Visium) explain what it took to make AI work across a global biopharma enterprise.

They cover why the hardest problems were organizational, how CSL gave every team a clear path from idea to production, and what changed once governance became part of the AI lifecycle. Pharmaceutical companies trying to scale AI beyond pilots will find three takeaways they can apply in their own organization. Watch to the end for the one thing that, in their words, ties it all together.